Analyst Rating Update on LDR Holding Corporation (LDRH)

LDR Holding Corporation (NASDAQ:LDRH) : 1 brokerage houses believe that LDR Holding Corporation (NASDAQ:LDRH) is a Strong Buy at current levels. 10 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on LDR Holding Corporation (NASDAQ:LDRH). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 11 Wall Street Analysts endorse the stock as a Hold with a rating of 2.82.

LDR Holding Corporation (NASDAQ:LDRH) : The consensus price target for LDR Holding Corporation (NASDAQ:LDRH) is $35.13 for the short term with a standard deviation of $3.83. The most optimist securities analyst among the 8 who monitor the stock believes that the stock can reach $38, however, the pessimist price target for the company is $28.

Company shares have received an average consensus rating of Hold for the current week

LDR Holding Corporation (NASDAQ:LDRH): On Tuesdays trading session , Opening price of the stock was $36.99 with an intraday high of $37.05. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $36.95. However, the stock managed to close at $36.96, a loss of 0.05% for the day. On the previous day, the stock had closed at $36.98. The total traded volume of the day was 844,593 shares.

In an insider trading activity,The officer (EVP, European Sales, Medical) of Ldr Holding Corp, Richard Patrick sold 25,000 shares at $27.6 on April 15, 2016. The Insider selling transaction had a total value worth of $690,000. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

LDR Holding Corporation is a global medical device company. The Company is focused on designing and commercializing surgical technologies for the treatment of patients suffering from spine disorders. The Companys primary products are based on its VerteBRIDGE fusion and Mobi non-fusion platforms, both of which are designed for applications in the cervical and lumbar spine. The Companys VerteBRIDGE products are designed around its plating technology that enables surgeons to implant VerteBRIDGE devices with direct visualization of the disc and to affix the devices to the vertebrae from inside the spinal disc space. The Companys Mobi non-fusion platform is highlighted by Mobi-C, a cervical disc replacement device with a patented mobile bearing core that is designed to replicate the natural anatomical movement of the spine by facilitating independent bending and twisting similar to a healthy disc.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.